共 50 条
The role of Pin1 in the development and treatment of cancer
被引:0
|作者:
Sang-Hyun Min
Xiao Zhen Zhou
Kun Ping Lu
机构:
[1] DGMIF,New Drug Development Center
[2] Harvard Medical School,Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Center for Life Science, Beth Israel Deaconess Medical Center
[3] Fujian Medical University,Institute for Translational Medicine
来源:
关键词:
Proline-directed phosphorylation;
Cancer-driving pathways;
Tumorigenesis;
Pin1;
Pin1 inhibitor;
Prolyl isomerase;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Protein phosphorylation and post-phosphorylation events regulate many cellular signaling pathways. Peptidyl-prolyl isomerase (Pin1) is the only peptidyl-prolyl cis/trans isomerase that interacts with numerous oncogenic or tumor suppressive phosphorylated proteins, causes conformational changes in target proteins, and eventually regulates the activities of such proteins. These alterations in activity play a pivotal role in tumorigenesis. Since Pin1 is overexpressed and/or activated in various types of cancers, and the dysregulation of proline-directed phosphorylation contributes to tumorigenesis, Pin1 represents an attractive target for cancer therapy. This review will describe the role of Pin1 in cancer and the current status of Pin1 inhibitor development.
引用
收藏
页码:1609 / 1620
页数:11
相关论文